Back Bay CEO Selected as Judge for BIO 2018 Start-Up Stadium
Jonathan P. Gertler
Boston, May 1, 2018—Back Bay Life Science Advisors, strategic and transactional advisors to the life science industry, announced today that Jonathan P. Gertler, Managing Partner and CEO, has been selected to judge the Start-up Stadium competition at the upcoming BIO International Convention (BIO 2018) June 4-7 in Boston.As the world’s largest biotechnology event, BIO 2018 provides several specialized opportunities geared toward start-up and emerging life science companies; the Start-Up Stadium provides startup biotech companies with unprecedented access and opportunities to the learn from life science industry leaders, who provide advice and leadership following company pitches. Guidance is offered to young biotech companies in the context of the larger BIO Exhibition, which features more than 1,800 exhibitors showing off the latest trends, technology, companies, and breakthrough ideas in biotech and pharmaceuticals.The Start-up Stadium’s panel of judges is selected from a wide range of subject-matter experts in biotech and pharma. With more than 30 years of clinical and scientific experience, and extensive advisory work with biotechnology, diagnostic, medical device and healthcare IT companies in both the private and public sector, Dr. Gertler is a frequent speaker and writer on strategic issues facing life science companies at all stages.“Guiding the next generation of biotech innovators is one of the things we do exceptionally well in the Boston biotech ecosystem,” said Dr. Gertler. “I’m pleased to be among the panel of experts providing advice from successes and mistakes in growing our own businesses and those of our partners and peers.”
About Back Bay Life Science Advisors
Back Bay Life Science Advisors provides strategy consulting and transaction advisory services to the life science industry. Our expertise spans the continuum of stage, sector, and geography, across every therapeutic class. We work with local and global biopharmaceutical and medical technology sectors on the buy and sell side of transaction execution, from gleam-in-the-eye preclinical technology platforms to 2 billion dollar established brands. Subscribe to Back Bay’s newsletter for industry insight and perspective, and learn about our life science experts at bblsa.com.
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.